These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2256448)

  • 21. Hypersensitive reactions on readministration of streptokinase following acute myocardial infarction.
    Sahay RN; Kalantri SP; Gupta OP
    J Assoc Physicians India; 1994 Oct; 42(10):815. PubMed ID: 7876052
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.
    Schweitzer DH; van der Wall EE; Bosker HA; Scheffer E; Macfarlane JD
    Cardiology; 1991; 78(1):68-71. PubMed ID: 2021968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse pulmonary hemorrhage after streptokinase administration for acute myocardial infarction.
    Swanson GA; Kaeley G; Geraci SA
    Pharmacotherapy; 1997; 17(2):390-4. PubMed ID: 9085336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 25. Streptokinase-induced jaundice in patients with acute myocardial infarction.
    Mager A; Birnbaum Y; Zlotikamien B; Strasberg B; Rechavia E; Sagie A; Sclarovsky S
    Am Heart J; 1991 May; 121(5):1543-4. PubMed ID: 2017987
    [No Abstract]   [Full Text] [Related]  

  • 26. Crescentic glomerulonephritis: a possible complication of streptokinase treatment for myocardial infarction.
    Murray N; Lyons J; Chappell M
    Br Heart J; 1986 Nov; 56(5):483-5. PubMed ID: 3790385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cholesterol embolization after intravenous streptokinase therapy in acute myocardial infarction].
    Bucher A; Roald B
    Tidsskr Nor Laegeforen; 1993 Jun; 113(15):1844-5. PubMed ID: 8322322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    de Swart JB
    Drugs; 1987; 33 Suppl 3():279-81. PubMed ID: 3315607
    [No Abstract]   [Full Text] [Related]  

  • 29. Streptokinase and low back pain.
    Bourke J
    N Z Med J; 1992 Nov; 105(946):482. PubMed ID: 1436882
    [No Abstract]   [Full Text] [Related]  

  • 30. Meningoencephalitis after streptokinase treatment.
    Wahlid ST; Bilous RW; Lilic D; Newman PK
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):132-3. PubMed ID: 11118267
    [No Abstract]   [Full Text] [Related]  

  • 31. Excessive megakaryocyte migration after thrombolytic therapy and benefit of aspirin with streptokinase.
    van Pampus EC; Huijgens PC; Verheugt FW; Langenhuijsen MM
    Lancet; 1992 Aug; 340(8817):492-3. PubMed ID: 1354825
    [No Abstract]   [Full Text] [Related]  

  • 32. Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction.
    Alexopoulos D; Collins R; Adamopoulos S; Peto R; Sleight P
    Br Heart J; 1991 Jan; 65(1):9-13. PubMed ID: 1993133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possibility of the recurrence of thrombosis during intracoronary administration of streptokinase in acute myocardial infarct].
    Vol'pert EI; Min'ko BA; Ryzhov EV; Kesler DF; Rezenberg LI
    Kardiologiia; 1984 Oct; 24(10):102-3. PubMed ID: 6521172
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholesterol embolization after systemic streptokinase.
    Wright DA; Forni LG; Carr P; Hilton PJ; Tungekar MF
    Br J Hosp Med; 1997 Jan 15-Feb 5; 57(1-2):51-2. PubMed ID: 9022828
    [No Abstract]   [Full Text] [Related]  

  • 35. Intrinsic spinal cord haemorrhage due to streptokinase treatment for myocardial infarction.
    Cruickshank GS; Duncan R; Hadley DM; Bone I
    J Neurol Neurosurg Psychiatry; 1992 Aug; 55(8):740. PubMed ID: 1527557
    [No Abstract]   [Full Text] [Related]  

  • 36. The safety and efficacy of streptokinase in coronary reperfusion in patients with acute myocardial infarction.
    Hu D
    Chin Med J (Engl); 1995 Apr; 108(4):291-4. PubMed ID: 7789218
    [No Abstract]   [Full Text] [Related]  

  • 37. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 38. Adult respiratory distress syndrome after streptokinase.
    Tio RA; Voorbij RH; Enthoven R
    Am J Cardiol; 1992 Dec; 70(20):1632-3. PubMed ID: 1466343
    [No Abstract]   [Full Text] [Related]  

  • 39. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC
    Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol embolisation syndrome after thrombolytic therapy for myocardial infarction.
    Pochmalicki G; Feldman L; Meunier P; Rougeot C; Weschler J; Jan F
    Lancet; 1992 Jan; 339(8784):58-9. PubMed ID: 1345976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.